Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
AverageWe are a leading global provider of mission-critical products and services to customers in the biopharma & healthcare, education & government, and advanced technologies & applied materials end markets. Our business model is grounded in supporting our customers from discovery to delivery and Avantor is embedded in virtually every stage of the most important research, scale-up and manufacturing activities in the industries we serve.
In the company’s own words · 10-K filed Feb 11, 2026 · SEC EDGAR
Business segments
Q1 2026 · $1.58BThe company’s own SEC segment disclosure.
- VWR Distribution Services$1.15B73%
- Bioscience Medtech Products$431.4M27%
Avantor, Inc. (AVTR) reported revenue of $1.58B in Q1 2026 (quarter ended March 31, 2026), up 0.0% from the same quarter a year earlier. That came with a gross margin of 32% and net income of $43M (2.7% of revenue). For the full year FY2025, revenue was $6.55B (−3.4% year on year) and net income −$530M. Its largest segment in 2026-Q1 was VWR Distribution Services at $1.15B, 73% of the disclosed total, just ahead of Bioscience Medtech Products at 27%.
Raw charts
11 series · TTMAs reported to the SEC, without any scoring.
Medical Instruments & Supplies
Ranks #22 of 27 by Smart Score